Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Ordinary Shares | 0 | $0 | $15.72 | Oct 1, 2024 | Direct |
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Option (right to buy) | 168K | Sep 27, 2024 | Direct | ||
NewAmsterdam Pharma Co N.V. | Chief Accounting Officer | Option (right to buy) | 150K | Jan 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Sep 27, 2024 | 3 | -$707K | 4 | Oct 1, 2024 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Chief Accounting Officer |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Chief Accounting Officer |